BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8786306)

  • 1. Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation.
    Kuprash DV; Osipovich OA; Pokholok DK; Alimzhanov MB; Biragyn A; Turetskaya RL; Nedospasov SA
    J Immunol; 1996 Apr; 156(7):2465-72. PubMed ID: 8786306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF and phorbol esters induce lymphotoxin-beta expression through distinct pathways involving Ets and NF-kappa B family members.
    Voon DC; Subrata LS; Karimi M; Ulgiati D; Abraham LJ
    J Immunol; 2004 Apr; 172(7):4332-41. PubMed ID: 15034048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
    Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
    J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the mouse lymphotoxin-beta receptor promoter.
    Muller P; Männel DN; Hehlgans T
    Eur Cytokine Netw; 2001; 12(2):325-30. PubMed ID: 11399522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells.
    Okada Y; Voznesensky O; Herschman H; Harrison J; Pilbeam C
    J Cell Biochem; 2000 May; 78(2):197-209. PubMed ID: 10842315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein.
    Del Vecchio I; Zuccotti A; Pisano F; Canneva F; Lenzken SC; Rousset F; Corsini E; Govoni S; Racchi M
    Gene; 2009 Feb; 430(1-2):17-29. PubMed ID: 19000751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide.
    Kuprash DV; Udalova IA; Turetskaya RL; Kwiatkowski D; Rice NR; Nedospasov SA
    J Immunol; 1999 Apr; 162(7):4045-52. PubMed ID: 10201927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the specific binding site of NF-k B-like factor at the 5' upstream region of human lymphotoxin gene].
    Xu R; Zhao S
    Yi Chuan Xue Bao; 1994; 21(6):417-23. PubMed ID: 7718273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of gene expression in mammary epithelial cells by cellular confluence and sequence-specific DNA binding factors.
    Altiok S; Groner B
    Biochem Soc Symp; 1998; 63():115-31. PubMed ID: 9513716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
    Yuan W; Yufit T; Li L; Mori Y; Chen SJ; Varga J
    J Cell Physiol; 1999 Apr; 179(1):97-108. PubMed ID: 10082137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter.
    Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH
    J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression.
    Force WR; Walter BN; Hession C; Tizard R; Kozak CA; Browning JL; Ware CF
    J Immunol; 1995 Dec; 155(11):5280-8. PubMed ID: 7594541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
    Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
    FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
    Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
    Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the TCA3 gene in mast cells after Fc epsilon RI cross-linking.
    Oh CK; Metcalfe DD
    J Immunol; 1994 Jul; 153(1):325-32. PubMed ID: 8207245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
    Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
    Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B; Safa AR
    Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.